Merck to Acquire Verona Pharma for $10 Billion in Strategic Push Beyond Keytruda
Summit Therapeutics Shares Surge on Reported $15B AstraZeneca Deal Talks
Novo Nordisk Stock Drops After Disappointing Weight-Loss Drug Trial and Hims & Hers Fallout
23andMe's Founder Anne Wojcicki is Taking Back Her DNA Testing Firm
U.S. States Sue 23andMe Over Sale of Private Genetic Data
FDA Approves Merck’s RSV Shot for Infants, Intensifying Competition with Sanofi and AstraZeneca
Neuralink Competitor Paradromics Achieves First Human Implant of Its Brain-Computer Interface
Regeneron’s Experimental Drug May Solve a Major Problem with Wegovy
Elon Musk's Neuralink Reaches $9 Billion Valuation
Top Biotech Stocks to Watch in May 2025
Pump Radar
Stock Alerts